Original Research
Published on 30 Apr 2024
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1369126
- 4,790 views
- 2 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,916 articles
articles
Systematic Review
Published on 24 Apr 2024
First-line immunotherapy efficacy in advanced squamous non-small cell lung cancer with PD-L1 expression ≥50%: a network meta-analysis of randomized controlled trials
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1365255
- 4,593 views
Case Report
Published on 23 Apr 2024
ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1395654
- 2,868 views
- 3 citations
Case Report
Published on 23 Apr 2024
Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1387388
- 2,653 views
Case Report
Published on 22 Apr 2024
Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1377451
- 4,871 views
- 6 citations
Original Research
Published on 22 Apr 2024
TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1357583
- 3,351 views
- 10 citations
Case Report
Published on 19 Apr 2024
Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1331387
- 2,630 views
- 3 citations
Editorial
Published on 19 Apr 2024
Editorial: Updates on combination therapy for lung cancer volume II
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1393278
- 1,288 views
Case Report
Published on 18 Apr 2024
Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1339511
- 2,570 views
- 1 citation
Original Research
Published on 18 Apr 2024
Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1285280
- 3,451 views
- 5 citations
Systematic Review
Published on 17 Apr 2024
Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1357248
- 3,135 views
- 6 citations
Case Report
Published on 16 Apr 2024
Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1370901
- 2,075 views
- 2 citations
Systematic Review
Published on 16 Apr 2024
Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1358101
- 5,571 views
- 6 citations
Case Report
Published on 15 Apr 2024
Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1378530
- 1,748 views
- 1 citation
Original Research
Published on 12 Apr 2024
Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1265228
- 2,495 views
- 3 citations
Original Research
Published on 10 Apr 2024
A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1328871
- 2,658 views
- 5 citations
Brief Research Report
Published on 10 Apr 2024
Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1363543
- 2,300 views
- 1 citation
Case Report
Published on 09 Apr 2024
A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1359985
- 1,866 views
Original Research
Published on 08 Apr 2024
A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1314301
- 3,611 views
- 7 citations
Correction
Published on 08 Apr 2024
Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1377858
- 1,022 views
Original Research
Published on 08 Apr 2024
Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1335009
- 2,175 views
- 1 citation
Case Report
Published on 04 Apr 2024
Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1368059
- 2,187 views
- 1 citation
Original Research
Published on 02 Apr 2024
Clinical significance of miR-9-5p in NSCLC and its relationship with smoking
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1376502
- 2,384 views
- 6 citations
Case Report
Published on 02 Apr 2024
Uniportal video-assisted thoracoscopic segmentectomy for fetal adenocarcinoma lung cancer with severe pulmonary emphysema: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1281211
- 1,534 views